Company Info






  Home > Archived Webinars >

Strategies for Preparing a Comprehensive Letter of Intent (LOI) in EU Life Science M&A & Private Equity Transactions
Strategies for Preparing a Comprehensive Letter of Intent (LOI) in EU Life Science M&A & Private Equity Transactions


 
Our Price: $395.00

Product Code: WB-7070
Qty:

Product Info
 
About the Product
Includes 1 hour and 10 minute Windows Media Video File and PowerPoint presentations for immediate download.

A letter of intent is a document used to formally state your intentions to enter serious negotiations and outlines the envisioned basic preliminary terms of a proposed business transaction, including the scope and the proposed price/valuation. In the life science industry, M&A and private equity transactions require numerous actions, meetings and investigation processes before completion can be expected. A comprehensive letter of intent defining the legal environment of negotiations is therefore usually considered as a crucial first step in pre-acquisition/investment planning and transaction structuring and must be adequately developed in a timely, compliant manner.
  • General principles and benefits of a LOI
  • Outlining the binding/ non-binding legal consequences
  • Standard headers and sections of a LOI specific to M&A and private equity transactions
  • Focus on specific “closing” and related conditions
  • Defining miscellaneous LOI considerations and their significance

Speaker:
Cristian Rawlins
Managing Partner
Duteil Avocats


Participants that will find this webinar most beneficial will be those involved in pharmaceutical, medical device and biotechnology companies. Job titles of attendees that will be most applicable for this session will be:

  • Business Development
  • General Counsel/ Legal Affairs
  • Mergers & Acquisitions
  • Finance Officers/Directors
  • President/Managing Director

Share your knowledge of this product. Be the first to write a review »